Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
68°
Clear
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about 5/MeO/DMT
Recent news which mentions 5/MeO/DMT
Imperial College Scientists Dose First Patient With 5-MeO-DMT To Examine One Of The Most Potent Psychedelics' Effects On The Brain
June 03, 2024
Tickers
NEWS
Tags
5/MeO/DMT
Tommaso Barba
psychedelics study
From
Benzinga
First Patient Dosed In Psychedelics Therapy Study For Treatment-Resistant Depression
April 26, 2024
Tickers
NEWS
Tags
BPL/003
Benzinga
Psychedelics
From
Benzinga
Intranasal 5-MeO-DMT Clinical Trial Offers Hope For Treatment-Resistant Depression
March 28, 2024
Tickers
ATAI
NEWS
Tags
5/MeO/DMT
Psychedelics Research
Psychedelic/Assisted Therapies
From
Benzinga
GH Research: This European Biotech Company Reports Full Year 2023 Financial Results And Business Updates
February 29, 2024
Tickers
GHRS
NEWS
Tags
Global
Cannabis
Market News
From
Benzinga
Atai Invests $50M In Beckley Psytech For Short-Duration Psychedelics Development
January 04, 2024
Tickers
ATAI
GHRS
NEWS
Tags
5/MeO/DMT
Financing
Psychedelics Investing
From
Benzinga
GH Research: Steady Expenses And $229M Cash Position For 2026 Runway
November 14, 2023
Tickers
GHRS
Tags
financial results
News
GHRS
From
Benzinga
GH Research's Psychedelic Drug Candidate For Depression Meets FDA: Clinical Program On Hold
October 02, 2023
Tickers
GHRS
Tags
Psychedelics
Benzinga
Psychedelic/Assisted Therapies
From
Benzinga
GH Research Psychedelics Firm Q2 2023 Reports $238M Cash To Accelerate 5-MeO-DMT Programs Into 2026
August 24, 2023
Tickers
GHRS
Tags
Benzinga
Psychedelics
Psychedelic/Assisted Therapies
From
Benzinga
Harnessing The Power Of 5-MeO-DMT For Women Trauma Survivors: A Specialized Retreat
July 03, 2023
Tags
Offerings
Markets
Cannabis
From
Benzinga
All On Board For 5-MeO-DMT: This Retreat Hosts Expertly Guided Experiences For Women, BIPOC
July 02, 2023
Tags
Global
Tandava Retreats
Market News
From
Benzinga
GH Research: Q1 2023 Financials And Businesses For European 5-MeO-DMT Depression Treatment Developer
May 11, 2023
Tickers
GHRS
Tags
Benzinga
Psychedelics
Biotech
From
Benzinga
Beckley Psytech Begins Phase IIa Study Of Psychedelic Compound To Treat Depression
May 04, 2023
Tags
Markets
Cannabis
Market News
From
Benzinga
UK-Based Approach To Alcohol Addiction: 5-MeO-DMT Candidate Moves To Phase 2 Clinical Stage
April 05, 2023
Tags
Markets
5/MeO/DMT
Beckley Psytech
From
Benzinga
2 Psychedelics Companies Tout Advanced Clinical Trials, Progress With Key Products
January 11, 2023
Tickers
GHRS
PHRRF
Tags
GHRS
Penny Stocks
Guidance
From
Benzinga
New Sublingual Psychedelic Drug Candidate Created For Depression And Anxiety In Alzheimer's
December 29, 2022
Tickers
BMNDF
Tags
5/MeO/DMT
BMNDF
Benzinga
From
Benzinga
Phase 2 Trial For This Psychedelic, Potential Treatment For Severe Depression
December 22, 2022
Tags
Markets
5/MeO/DMT
Beckley Psytech
From
Benzinga
Psychedelic Experiences: UCL Leads First-Ever Brain Imaging Study In Retreat Participants
December 07, 2022
Tags
News
Global
Cannabis
From
Benzinga
Beyond Magic Mushrooms: Positive Clinical Trial For Treatment-Resistant Depression & Alcoholism
November 16, 2022
Tags
Psychedelics
Benzinga
News
From
Benzinga
Psychedelics Company's $60M Series A For Startup To Develop Treatment For Mental Health Disorders
November 02, 2022
Tags
News
Lusaris Therapeutics
Contracts
From
Benzinga
Can Psychedelics Alleviate Prolonged Grief? Austin's Dell Med School Launches Clinical Trial To Find Out
October 18, 2022
Tags
5/MeO/DMT
military veterans
Gold Star Wives
From
Benzinga
Canadian Psychedelics Firm And Queens College Develop New Transdermal Drug Delivery System
September 27, 2022
Tickers
BMNDF
Tags
Queen’s University of Belfast
5/MeO/DMT
Psychedelics
From
Benzinga
Clinical Study On DMT Inhaled Product For Treatment-Resistant Depression Completes Dosing Stage
September 23, 2022
Tickers
BMNDF
Tags
Alejandro Antalich
News
Penny Stocks
From
Benzinga
DMT Producer PsyBio And Shrooms Grower Red Light Holland Share Their Most Recent Financial Results
August 29, 2022
Tickers
DMT
PSYBF
TRUFF
Tags
Cannabis
Market News
Markets
From
Benzinga
GH Research Shares Q2 2022 Financial Results & Business Updates
August 23, 2022
Tickers
GHRS
Tags
Small Cap
5/MeO/DMT
Management
From
Benzinga
Inside A 5-MeO-DMT Retreat: Who Should And Shouldn't Embark On This 'Hero's Journey'
February 12, 2022
Tickers
DMT
Tags
Cannabis
Market News
Markets
From
Benzinga
5 Psychedelics For Mental Health
February 01, 2022
Tags
contributors
psychedelics
Markets
From
Benzinga
Beckley Psytech Begins Training Therapists For Phase 2 Trial With Toad Venom, 5-MeO-DMT
January 24, 2022
Tags
Markets
5/MeO/DMT
Beckley Psytech
From
Benzinga
A Deeper Look At DMT, The 'Spirit Molecule'
January 12, 2022
Tickers
DMT
Tags
contributors
DMT
Benzinga
From
Benzinga
GH Research Announces Positive Trial Results For Treatment-Resistant Depression
December 06, 2021
Tickers
GHRS
Tags
Small Cap
General
Topics
From
Benzinga
Mike Tyson: How A Drug Derived From Toad Venom Made Him Comfortable With Dying
November 16, 2021
Tickers
GHRS
Tags
Benzinga
Small Business
Sonoran desert toad
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.